Indicated as monotherapy for adults with HR-good, HER2-damaging Superior or metastatic breast most cancers with ailment progression pursuing endocrine therapy and prior chemotherapy in metastatic setting 200 mg PO BID This part collects any knowledge citations, info availability statements, or su